A digital toolkit with patient scripts, risk calculator comparisons and more could help primary care and OB/GYN providers ...
More than one-third of U.S. adults diagnosed with metastatic HER2-negative breast cancer in 2023 did not undergo testing for BRCA mutations, according to a retrospective analysis.Less than half ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback